Mortality trends of liver diseases from 1981 to 2016 and the projection to 2035 in Taiwan: An age‐period‐cohort analysis
- 16 December 2018
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 39 (4), 770-776
- https://doi.org/10.1111/liv.14027
Abstract
Background Projections on liver diseases mortality can provide a basis for evaluating the World Health Organization's “25 by 25” goal and can help health care systems design appropriate control strategies. This study evaluated whether the 25 by 25 goal can be achieved in Taiwan and discussed possible future control strategies. Methods Age–period–cohort models are used to estimate the mortality trends of liver diseases from 1981 to 2016 and project these trends to 2035. Results For chronic liver disease and cirrhosis among men, the age‐adjusted mortality rate decreased from 1981 to 1991, increased until 1999, and subsequently decreased again until 2016. For women, the age‐adjusted mortality rate exhibited an increasing but up‐and‐down trend from 1981 to 1998 and a decreasing trend to 2016. For liver cancer among men, the age‐adjusted mortality rate exhibited an increasing trend from 1981 to 2002 and a decreasing trend to 2016. For women, the age‐adjusted mortality rate exhibited an increasing trend from 1981 to 2003 and a decreasing trend to 2016. The age‐adjusted mortality rates of chronic liver disease, cirrhosis, and liver cancer for both sexes are projected to decrease by more than 30% from 2016 to 2025 and by more than 55% from 2016 to 2035. Conclusion These results indicated that the 25 by 25 goal can be achieved for liver diseases mortality in Taiwan. In addition to viral hepatitis, the following risk factors may become the major causes of liver diseases in Taiwan in the future: alcohol and tobacco use, diabetes, and obesity.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST 104-2314-B-002-118-MY3, MOST 105-2314-B-002-049-MY3, MOST 107-3017-F-002-003)
- Ministry of Education (NTU-107L9003)
This publication has 26 references indexed in Scilit:
- Changes in Serum Levels of HBV DNA and Alanine Aminotransferase Determine Risk for Hepatocellular CarcinomaGastroenterology, 2011
- Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individualsBMC Cancer, 2011
- Hepatitis C Virus Seromarkers and Subsequent Risk of Hepatocellular Carcinoma: Long-Term Predictors From a Community-Based Cohort StudyJournal of Clinical Oncology, 2010
- Age-Period-Cohort Analysis of Hepatocellular Carcinoma Mortality in Taiwan, 1976–2005Annals of Epidemiology, 2009
- Nationwide Hepatitis B Vaccination Program in Taiwan: Effectiveness in the 20 Years After It Was LaunchedEpidemiologic Reviews, 2006
- Hepatitis B Vaccination in High‐Risk Infants: 10‐Year Follow‐UpThe Journal of Infectious Diseases, 1999
- Universal Hepatitis B Vaccination in Taiwan and the Incidence of Hepatocellular Carcinoma in ChildrenThe New England Journal of Medicine, 1997
- Hepatitis B Vaccination and Hepatocellular Carcinoma in TaiwanPEDIATRICS, 1997
- A pragmatic view of accuracy measurement in forecastingOmega, 1986
- HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS: A Prospective Study of 22 707 Men in TaiwanThe Lancet, 1981